Christian Nolet
Directeur/Membre du Conseil chez REVANCE THERAPEUTICS, INC.
Fortune : 188 176 $ au 30/06/2024
Profil
Mr. Christian W.
Nolet, CPA, is an Independent Director at Arrivent BioPharma, Inc., an Independent Director at Jasper Therapeutics, Inc., an Independent Director at Revance Therapeutics, Inc., a Member at California Society of Certified Public Accountants and a Member at The American Institute of Certified Public Accountants.
He is on the Board of Directors at Arrivent BioPharma, Inc., Jasper Therapeutics, Inc. and Revance Therapeutics, Inc. Mr. Nolet was previously employed as an Independent Director by Ambrx Biopharma, Inc /Old/, an Independent Director by PolarityTE, Inc., an Independent Director by Viela Bio, Inc., an Audit Partner by Ernst & Young LLP, and a Partner by PricewaterhouseCoopers LLP.
He also served on the board at Ambrx, Inc., Polarityte, Inc. /Brauser/, California Life Sciences Association and Center for Drug Evaluation & Research.
He received his undergraduate degree from San Diego State University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 01/05/2024 | 43 606 ( 0,04% ) | 112 067 $ | 30/06/2024 | |
| 06/06/2024 | 3 250 ( 0,02% ) | 73 775 $ | 30/06/2024 | |
REGENETP INC.
0,20% | 12/01/2023 | 14 403 ( 0,20% ) | 2 333 $ | 30/06/2024 |
ARRIVENT BIOPHARMA, INC.
-.--% | 25/01/2024 | 0 ( -.--% ) | - $ | 30/06/2024 |
Postes actifs de Christian Nolet
| Sociétés | Poste | Début |
|---|---|---|
| REVANCE THERAPEUTICS, INC. | Directeur/Membre du Conseil | 16/07/2019 |
| JASPER THERAPEUTICS, INC. | Directeur/Membre du Conseil | 24/09/2021 |
| ARRIVENT BIOPHARMA, INC. | Directeur/Membre du Conseil | 20/09/2023 |
The American Institute of Certified Public Accountants
 The American Institute of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services The American Institute of Certified Public Accountants provides vocational education in accounting. The company provides services to the accounting community, regulatory bodies, and other organizations. It also operates in Jersey City, Washington, and Lewisville. It was founded in 1887 and is headquartered in New York City, NY. | Corporate Officer/Principal | - |
| California Society of Certified Public Accountants | Corporate Officer/Principal | - |
Anciens postes connus de Christian Nolet
| Sociétés | Poste | Fin |
|---|---|---|
| REGENETP, INC. | Directeur/Membre du Conseil | 12/01/2023 |
| AMBRX INC | Directeur/Membre du Conseil | 01/11/2021 |
Ambrx Biopharma, Inc.
 Ambrx Biopharma, Inc. BiotechnologyHealth Technology Ambrx Biopharma Cayman, Inc. operates as a clinical-stage biologics company. It focuses on discovering and developing a novel class of engineered precision biologics using its proprietary expanded genetic code technology platform that allows it to incorporate, in a site-specific manner, synthetic amino acids that do not exist in nature into proteins within living cells. The company was founded in January 2003 and is headquartered in La Jolla, CA. | Directeur/Membre du Conseil | 01/11/2021 |
| VIELA BIO, INC. | Directeur/Membre du Conseil | 15/03/2021 |
Formation de Christian Nolet
| San Diego State University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 4 |
|---|---|
| REVANCE THERAPEUTICS, INC. | Health Technology |
| REGENETP, INC. | Health Technology |
| JASPER THERAPEUTICS, INC. | Finance |
| ARRIVENT BIOPHARMA, INC. | Health Technology |
| Entreprise privées | 9 |
|---|---|
Ernst & Young LLP
 Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Commercial Services |
Viela Bio, Inc.
 Viela Bio, Inc. BiotechnologyHealth Technology Viela Bio, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of treatment for autoimmune and inflammatory diseases. The firms product candidate includes inebilizumab, which is a humanized monoclonal antibody (mAb), designed to target CD19, a molecule expressed on the surface of a broad range of immune system B cells; VIB4920, which is a fusion protein designed to bind to CD40L on activated T cells, blocking their interaction with CD40-expressing B cells and potentially other binding partners; and VIB7734, which is a humanized mAb intended to be a novel treatment for autoimmune diseases where the pathology is driven principally by overproduction of type I interferons and other cytokines secreted by pDCs. The company was founded on December 11, 2017 and is headquartered in Gaithersburg, MD. | Health Technology |
The American Institute of Certified Public Accountants
The American Institute of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services The American Institute of Certified Public Accountants provides vocational education in accounting. The company provides services to the accounting community, regulatory bodies, and other organizations. It also operates in Jersey City, Washington, and Lewisville. It was founded in 1887 and is headquartered in New York City, NY. | Commercial Services |
| California Society of Certified Public Accountants | |
PricewaterhouseCoopers LLP
 PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY. | Commercial Services |
Ambrx, Inc.
 Ambrx, Inc. Pharmaceuticals: MajorHealth Technology Ambrx, Inc. engages in discovering and developing of protein therapeutics. It offers non-native amino acids through expanded genetic code to both generate novel bio-therapeutics. The company was founded by Richard DiMarchi, Peter G. Schultz, and Troy E. Wilson on April 15, 2003 and is headquartered in La Jolla, CA. | Health Technology |
California Life Sciences Association
 California Life Sciences Association Miscellaneous Commercial ServicesCommercial Services California Life Sciences Association (CLSA) is the largest and most influential life sciences advocacy and business leadership organization in California. The non-profit company is based in South San Francisco, CA, and has offices in other locations as well. The company works closely with industry, government, academia, and others to shape public policy, improve access to innovative technologies, and grow California's life sciences economy. CLSA serves biotechnology, pharmaceutical, medical device, and diagnostics companies, research universities and institutes, investors, and service providers throughout the state. Mike Guerra has been the CEO of the company since 2019. | Commercial Services |
Ambrx Biopharma, Inc.
Ambrx Biopharma, Inc. BiotechnologyHealth Technology Ambrx Biopharma Cayman, Inc. operates as a clinical-stage biologics company. It focuses on discovering and developing a novel class of engineered precision biologics using its proprietary expanded genetic code technology platform that allows it to incorporate, in a site-specific manner, synthetic amino acids that do not exist in nature into proteins within living cells. The company was founded in January 2003 and is headquartered in La Jolla, CA. | Health Technology |
| Center for Drug Evaluation & Research | Government |
